Clinical Trial Update: Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating reduction of Methicillin-resistant Staphylococcus aureus infection in skin ulcers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection
• Skin Ulcers

Snippet

Sponsor: Nitric BioTherapeutics, Inc | Conditions: Skin Ulcers, Methicillin-resistant Staphylococcus Aureus Infection | Phase 2 | Status: TERMINATED